PUBLICATION

Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases

Authors
Rezzola, S., Paganini, G., Semeraro, F., Presta, M., Tobia, C.
ID
ZDB-PUB-160420-12
Date
2016
Source
Biochimica et biophysica acta. Molecular basis of disease   1862(7): 1291-6 (Review)
Registered Authors
Presta, Marco, Tobia, Chiara
Keywords
Angiogenesis, Angiogenesis inhibitors, Embryonic development, Vascular retina diseases, Zebrafish
MeSH Terms
  • Angiogenesis Inhibitors/pharmacology*
  • Angiogenesis Inhibitors/therapeutic use
  • Animals
  • Disease Models, Animal
  • Drug Evaluation, Preclinical/methods*
  • Humans
  • Neovascularization, Pathologic/drug therapy*
  • Neovascularization, Pathologic/pathology
  • Retina/drug effects*
  • Retina/pathology
  • Retinal Neovascularization/drug therapy*
  • Retinal Neovascularization/pathology
  • Zebrafish/embryology*
PubMed
27085972 Full text @ BBA Molecular Basis of Disease
Abstract
Pathological angiogenesis of the retina is a main cause of blindness. Therapeutic approaches targeting vascular endothelial growth factor, a main angiogenesis inducer in retinal vascular diseases, show significant limitations. Thus, experimental models of retinal neovascularization remain crucial for investigating novel anti-angiogenic strategies and bringing them to patients. Recent observations have shown that eye neovascularization in zebrafish (Danio rerio) embryo may represent a novel target for the identification of angiogenesis inhibitors. This review highlights the use of zebrafish embryo as an innovative model system for the screening of anti-angiogenic molecules to be employed for the treatment of angiogenesis-dependent eye diseases.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping